4//SEC Filing
Frantz John R 4
Accession 0001209191-20-005233
CIK 0000708818other
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 6:18 PM ET
Size
8.3 KB
Accession
0001209191-20-005233
Insider Transaction Report
Form 4
Frantz John R
CEO and President
Transactions
- Award
Common Stock
2020-01-27+236,230→ 494,405 total - Award
Performance Stock Unit
2020-01-27+119,559→ 221,159 total→ Common Stock (119,559 underlying)
Footnotes (2)
- [F1]The shares of restricted stock vest over three years from December 26, 2019 in semi-annual increments as follows: 16.66% vest at 6 months; 16.66% vest at 12 months, 16.66% vest at 18 months, 16.66% vest at 24 months, 16.66% vest at 30 months, and 16.7% vest at 36 months, subject to continued service through each vesting date.
- [F2]The performance stock unit awards vest only in the event certain performance goals are achieved and there is continuous service through the date the goals are certified. Approximately 80% of the performance stock units are tied to the Company's fiscal year 2021 revenue goal and 20% are tied to the Company's fiscal year 2022 revenue goal. Performance stock unit awards funded for fiscal year 2021 and fiscal year 2022 revenue performance will be modified for cumulative 3-year total shareholder return ("TSR") on the three-year grant anniversary, which is also the cliff vest date. The number of shares to be issued may vary between 50% and 150% of the number of performance stock units depending on performance, and no such shares will be issued if threshold performance is not achieved.
Documents
Issuer
NEXTGEN HEALTHCARE, INC.
CIK 0000708818
Entity typeother
Related Parties
1- filerCIK 0001645338
Filing Metadata
- Form type
- 4
- Filed
- Jan 27, 7:00 PM ET
- Accepted
- Jan 28, 6:18 PM ET
- Size
- 8.3 KB